Jason McKinnie is a registered patent attorney focusing his practice on intellectual property matters including prosecution and litigation. Additionally, Mr. McKinnie's practice includes general business litigation in both state and federal, including subject matters such as environmental law.
Mr. McKinnie graduated from St. Mary's University School of Law in May 2009 where he served as a staff writer and an Associate Editor on the St. Mary's Law Journal. Mr. McKinnie received his Bachelor's of Science in Genetics from Texas A&M University in 2001, where he went on to receive a Master's of Public Health with a concentration in Health Policy and Management from the Texas A&M Health Science Center School of Rural Public Health. During his undergraduate studies, Mr. McKinnie worked for three years in a biochemistry laboratory conducting cutting edge research on chromatin remodeling.
Prior to entering law school in 2007, Mr. McKinnie served as an industry analyst for a consulting company covering the biotechnology and pharmaceutical markets with a specific focus on the oncology and drug delivery markets. Mr. McKinnie also served as a Contributing Editor for Drug Delivery Technology where he wrote multiple articles regarding various drug technologies including nanobiotechnology.
In his free time, Mr. McKinnie enjoys spending time with his wife Kendra and their dog. Together, they enjoy going to the Texas Hill Country and spending time with friends and family.
Gunn, Lee & Cave, P.C., 2009–present
Intellectual Property Law Firm
Patent Attorney, San Antonio Texas
Frost & Sullivan, 2004–2007
Biotechnology and Pharmaceutical Industry Analyst, San Antonio, Texas
Drug Delivery Technology, 2006–2008
Contributing Editor
BCS Heart Diagnostic, 2003–2004
Cardiovascular Technician, College Station, Texas
Biochemistry Lab of Mike Kladde Ph.D., Texas A&M University, 1999–2002
Research Assistant/Student Research Assistant
"Effectively Managing Litigation for In-House Counsel," 6th Annual Advanced Patent Litigation Course, Intellectual Property Law Section, State Bar of Texas, July 29-30, 2010.
"Smaller is Better," Pharmaceutical Executive, October 2006.
"The Future of Transdermal Delivery Relies on Active Patch Delivery," Drug Delivery Technology, Vol. 6, No. 8, September 2006.
"Nanobiotechnolgy: Delivering Revenue, Exciting Promise for the Future," Drug Delivery Technology, Vol. 6, No. 6, June 2006.
"Efficient R&D Expenditures Key to Successful Growth," Specialty Pharma, Vol. 2, No. 2, March/April 2006.
"Peptide Delivery Seeking to Become a Profitable Endeavor through New Technologies," Drug Delivery Technology, Vol. 6, No. 3, March 2006.
"Nanobiotechnology Offers a Promising Solution to Overcoming Common Drug Delivery Failures," Drug Delivery Technology, Vol. 5, No. 7, July/August 2005.